Explore more publications!

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on December 18, 2025

Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
Senti Biosciences Announces New Employment Inducement Grants
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Parker Seminars Announces Las Vegas 2026 (Feb. 26–28): The World’s Largest Chiropractic & Healthcare Event Celebrates 75 Years
Crescent Biopharma Announces Grants of Inducement Awards
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Abivax to be Added to Nasdaq Biotechnology Index
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD
Cue Biopharma Announces Proposed Public Offering
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Galapagos maakt topline resultaten bekend van twee fase 3-enabling studies met selectieve TYK2-remmer GLPG3667 bij dermatomyositis en systemische lupus erythematodes
Talkspace Releases Family Guide on Why Stress Spikes in December, and How to Break the Cycle

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions